| Year |
Citation |
Score |
| 2021 |
Okoye NC, Phelps TE, Charles A, McCormick JB, Wycoff DE, Lydon JD, Embree MF, Guthrie J, Kelley SP, Barnes CL, Ketring AR, Hennkens HM, Jurisson SS. Recovery, recycling and re-irradiation of enriched Ru metal targets for cost effective production of Rh. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 176: 109847. PMID 34218122 DOI: 10.1016/j.apradiso.2021.109847 |
0.537 |
|
| 2018 |
Feng Y, Phipps MD, Phelps TE, Okoye NC, Baumeister JE, Wycoff DE, Dorman EF, Wooten AL, Vlasenko V, Berendzen AF, Wilbur DS, Hoffman TJ, Cutler CS, Ketring AR, Jurisson SS. Evaluation of Se/As generator and production of Se for supplying As as a potential PET imaging radionuclide. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 143: 113-122. PMID 30408634 DOI: 10.1016/J.Apradiso.2018.10.026 |
0.562 |
|
| 2018 |
Feng Y, DeGraffenreid AJ, Phipps MD, Rold TL, Okoye NC, Gallazzi FA, Barnes CL, Cutler CS, Ketring AR, Hoffman TJ, Jurisson SS. A trithiol bifunctional chelate forAs: A matched pair theranostic complex with high in vivo stability. Nuclear Medicine and Biology. 61: 1-10. PMID 29571038 DOI: 10.1016/J.Nucmedbio.2018.03.001 |
0.58 |
|
| 2017 |
Feng Y, Phelps TE, Carroll V, Gallazzi F, Sieckman G, Hoffman TJ, Barnes CL, Ketring AR, Hennkens HM, Jurisson SS. Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment. Dalton Transactions (Cambridge, England : 2003). PMID 28951905 DOI: 10.1039/C7Dt02407J |
0.565 |
|
| 2017 |
Mastren T, Radchenko V, Bach HT, Balkin ER, Birnbaum ER, Brugh M, Engle JW, Gott MD, Guthrie J, Hennkens HM, John KD, Ketring AR, Kuchuk M, Maassen JR, Naranjo CM, et al. Bulk production and evaluation of high specific activity (186g)Re for cancer therapy using enriched (186)WO3 targets in a proton beam. Nuclear Medicine and Biology. 49: 24-29. PMID 28288384 DOI: 10.1016/J.Nucmedbio.2017.02.006 |
0.572 |
|
| 2017 |
Balkin ER, Gagnon K, Dorman E, Emery R, Li Y, Wooten AL, Smith BE, Strong KT, Pauzauskie PJ, Fassbender ME, Cutler CS, Ketring AR, Jurisson SS, Wilbur DS. Scale-up of high specific activity 186gRe production using graphite-encased thick 186W targets and demonstration of an efficient target recycling process Radiochimica Acta. 105. DOI: 10.1515/Ract-2017-2780 |
0.559 |
|
| 2016 |
DeGraffenreid AJ, Feng Y, Wycoff DE, Morrow R, Phipps MD, Cutler CS, Ketring AR, Barnes CL, Jurisson SS. Dithiol Aryl Arsenic Compounds as Potential Diagnostic and Therapeutic Radiopharmaceuticals. Inorganic Chemistry. PMID 27453472 DOI: 10.1021/Acs.Inorgchem.6B01175 |
0.559 |
|
| 2016 |
Balkin ER, Gagnon K, Strong KT, Smith BE, Dorman EF, Emery RC, Pauzauskie PJ, Fassbender ME, Cutler CS, Ketring AR, Jurisson SS, Wilbur DS. Deuteron irradiation of W and WO3 for production of high specific activity (186)Re: Challenges associated with thick target preparation. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 115: 197-207. PMID 27423020 DOI: 10.1016/J.Apradiso.2016.06.021 |
0.577 |
|
| 2016 |
Gott MD, Hayes CR, Wycoff DE, Balkin ER, Smith BE, Pauzauskie PJ, Fassbender ME, Cutler CS, Ketring AR, Wilbur DS, Jurisson SS. Accelerator-based production of the (99m)Tc-(186)Re diagnostic-therapeutic pair using metal disulfide targets (MoS2, WS2, OsS2). Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 114: 159-166. PMID 27236832 DOI: 10.1016/J.Apradiso.2016.05.024 |
0.574 |
|
| 2016 |
DeGraffenreid AJ, Feng Y, Barnes CL, Ketring AR, Cutler CS, Jurisson SS. Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals. Nuclear Medicine and Biology. 43: 288-95. PMID 27150031 DOI: 10.1016/J.Nucmedbio.2016.01.005 |
0.567 |
|
| 2016 |
Gott MD, DeGraffenreid AJ, Feng Y, Phipps MD, Wycoff DE, Embree MF, Cutler CS, Ketring AR, Jurisson SS. Chromatographic separation of germanium and arsenic for the production of high purity (77)As. Journal of Chromatography. A. PMID 26947162 DOI: 10.1016/J.Chroma.2016.02.074 |
0.526 |
|
| 2016 |
DeGraffenreid AJ, Feng Y, Barnes CL, Ketring AR, Cutler CS, Jurisson SS. Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals Nuclear Medicine and Biology. 43: 288-295. DOI: 10.1016/j.nucmedbio.2016.01.005 |
0.471 |
|
| 2014 |
Wycoff DE, Gott MD, DeGraffenreid AJ, Morrow RP, Sisay N, Embree MF, Ballard B, Fassbender ME, Cutler CS, Ketring AR, Jurisson SS. Chromatographic separation of selenium and arsenic: A potential (72)Se/(72)As generator. Journal of Chromatography. A. 1340: 109-14. PMID 24679827 DOI: 10.1016/J.Chroma.2014.03.033 |
0.538 |
|
| 2014 |
Gott MD, Ballard BD, Redman LN, Maassen JR, Taylor WA, Engle JW, Nortier FM, Birnbaum ER, John KD, Wilbur DS, Cutler CS, Ketring AR, Jurisson SS, Fassbender ME. Radiochemical study of re/w adsorption behavior on a strongly basic anion exchange resin Radiochimica Acta. 102: 325-332. DOI: 10.1515/Ract-2013-2144 |
0.502 |
|
| 2013 |
Fassbender ME, Ballard B, Birnbaum ER, Engle JW, John KD, Maassen JR, Nortier FM, Lenz JW, Cutler CS, Ketring AR, Jurisson SS, Wilbur DS. Proton irradiation parameters and chemical separation procedure for the bulk production of high-specific-activity 186gRe using WO3 targets Radiochimica Acta. 101: 339-346. DOI: 10.1524/Ract.2013.2031 |
0.588 |
|
| 2012 |
Jurisson SS, Wycoff DE, Degraffenreid A, Embree MF, Ketring AR, Cutler CS, Fassbender ME, Ballard B. Separation methods for high specific activity radioarsenic Aip Conference Proceedings. 1509: 215-217. DOI: 10.1063/1.4773971 |
0.477 |
|
| 2012 |
Bertch TC, Russ BE, Brown LC, Cutler CS, Ketring AR, Jurisson SS, Robertson JD. Selective gaseous extraction for low waste LEU-based economic isotope production Transactions of the American Nuclear Society. 107: 67. |
0.474 |
|
| 2011 |
Mohsin H, Jia F, Bryan JN, Sivaguru G, Cutler CS, Ketring AR, Miller WH, Simón J, Frank RK, Theodore LJ, Axworthy DB, Jurisson SS, Lewis MR. Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu. Bioconjugate Chemistry. 22: 2444-52. PMID 22053899 DOI: 10.1021/Bc200258X |
0.531 |
|
| 2006 |
Mohsin H, Jia F, Sivaguru G, Hudson MJ, Shelton TD, Hoffman TJ, Cutler CS, Ketring AR, Athey PS, Simón J, Frank RK, Jurisson SS, Lewis MR. Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu. Bioconjugate Chemistry. 17: 485-92. PMID 16536481 DOI: 10.1021/Bc0502356 |
0.56 |
|
| 2004 |
Lewis MR, Zhang J, Jia F, Owen NK, Cutler CS, Embree MF, Schultz J, Theodore LJ, Ketring AR, Jurisson SS, Axworthy DB. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice. Nuclear Medicine and Biology. 31: 213-23. PMID 15013487 DOI: 10.1016/J.Nucmedbio.2003.08.004 |
0.546 |
|
| 2003 |
Li WP, Smith CJ, Cutler CS, Hoffman TJ, Ketring AR, Jurisson SS. Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149Pm. Nuclear Medicine and Biology. 30: 241-51. PMID 12745015 DOI: 10.1016/S0969-8051(02)00418-3 |
0.577 |
|
| 2001 |
Li WP, Ma DS, Higginbotham C, Hoffman T, Ketring AR, Cutler CS, Jurisson SS. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. Nuclear Medicine and Biology. 28: 145-54. PMID 11295425 DOI: 10.1016/S0969-8051(00)00196-7 |
0.578 |
|
| 2001 |
Barnholtz SL, Lydon JD, Huang G, Venkatesh M, Barnes CL, Ketring AR, Jurisson SS. Syntheses and characterization of gold(III) tetradentate schiff base complexes. X-ray crystal structures of [Au(sal2pn)]Cl·2.5H2O and [Au(sal2en)]PF6 Inorganic Chemistry. 40: 972-976. DOI: 10.1021/Ic001073M |
0.514 |
|
| 2000 |
Jia W, Ma D, Volkert EW, Ketring AR, Ehrhardt GJ, Jurisson SS. Production of No-Carrier-Added 105Rh from Neutron Irradiated Ruthenium Target Platinum Metals Review. 44: 50-55. |
0.511 |
|
| 1999 |
Venkatesh M, Schlemper EO, Jurisson SS, Ketring AR, Volkert WA, Corlija M. Preparation of 105 Rh labeled monoclonal antibody (MAb B72.3) using aminobenzylpropyleneamineoxime as the bifunctional chelating agent; Comparison to 131 I labeled MAb B72.3 Radiochimica Acta. 85: 157-163. DOI: 10.1524/Ract.1999.85.34.157 |
0.517 |
|
| 1999 |
Hu F, Lydon JD, Jurisson S, Ketring A. Rhodium (III) complexes with acyclic tetrathioether ligands: Potential bifunctional chelates for use in radiotherapy Journal of Labelled Compounds and Radiopharmaceuticals. 42: S818-S820. |
0.527 |
|
| 1998 |
Berning DE, Katti KV, Volkert WA, Higginbotham CJ, Ketring AR. 198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals. Nuclear Medicine and Biology. 25: 577-83. PMID 9751426 DOI: 10.1016/S0969-8051(98)00023-7 |
0.375 |
|
| 1998 |
Ehrhardt GJ, Ketring AR, Ayers LM. Reactor-produced radionuclides at the University of Missouri Research Reactor. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 49: 295-7. PMID 9519439 DOI: 10.1016/S0969-8043(97)00038-9 |
0.31 |
|
| 1997 |
Li N, Struttman M, Higginbotham C, Grall AJ, Skerlj JF, Vollano JF, Bridger SA, Ochrymowycz LA, Ketring AR, Abrams MJ, Volkert WA. Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats. Nuclear Medicine and Biology. 24: 85-92. PMID 9080479 DOI: 10.1016/S0969-8051(96)00177-1 |
0.328 |
|
| 1997 |
Jurisson SS, Ketring AR, Volkert WA. Rhodium-105 complexes as potential radiotherapeutic agents Transition Metal Chemistry. 22: 315-317. DOI: 10.1023/A:1018441230403 |
0.595 |
|
| 1996 |
Venkatesh M, Goswami N, Volkert WA, Schlemper EO, Ketring AR, Barnes CL, Jurisson S. An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates. Nuclear Medicine and Biology. 23: 33-40. PMID 9004912 DOI: 10.1016/0969-8051(95)02012-8 |
0.587 |
|
| 1996 |
Reddy VS, Berning DE, Katti KV, Barnes CL, Volkert WA, Ketring AR. Chemistry in Environmentally Benign Media. 3.1Synthesis and Characterization of Rhenium(V) Complexes Derived from Novel Water-Soluble (Hydroxymethyl)phosphines. Crystal Structures of [Re(O)2{(HOH2C)2PC6H4P(CH2OH)2}2]I and [Re(O)2{(HOH2C)2PCH2CH2P(CH2OH)2}2]Cl Inorganic Chemistry. 35: 1753-1757. DOI: 10.1021/Ic9510167 |
0.325 |
|
| 1995 |
Singh PR, Lusiak P, Volkert WA, Ketring AR, Holmes RA, Katti KV. Transition metal chemistry of main group hydrazides, Part 14: Evaluation of new Tc-99m chelates of thiol functionalized phosphorus hydrazides. Nuclear Medicine and Biology. 22: 849-57. PMID 8547882 DOI: 10.1016/0969-8051(95)00023-Q |
0.341 |
|
| 1995 |
Katti KK, Singh PR, Volkert WA, Anderson CJ, Welch MJ, Hoffman T, Katti KV, Ketring AR, Wang M. Synthesis and characterization of a neutral and lipophilic Ph3PN99mTcO3 complex Applied Radiation and Isotopes. 46: 53-58. DOI: 10.1016/0969-8043(94)00083-C |
0.337 |
|
| 1994 |
Singh PR, Katti KK, Katti KV, Corlija M, Ketring AR, Volkert WA, Holmes RR. A new 99mTc-complex with a germanium-hydrazide (GeTH) ligand. Nuclear Medicine and Biology. 21: 1115-8. PMID 9234370 DOI: 10.1016/0969-8051(94)90184-8 |
0.364 |
|
| 1993 |
Katti KV, Singh PR, Barnes CL, Katti KK, Kopicka K, Ketring AR, Volkert WA. The Potential of Phosphinimines as Building Blocks for a new Generation of Radiopharmaceuticals Phosphorus, Sulfur, and Silicon and the Related Elements. 75: 55-58. DOI: 10.1080/10426509308037363 |
0.304 |
|
| 1992 |
Singh PR, Corlija M, Troutner DE, Ketring AR, Volkert WA. Synthesis, characterization and biodistribution studies of a neutral-lipophilic Tc-99m N3S2 chelate. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 19: 791-5. PMID 1399701 DOI: 10.1016/0883-2897(92)90141-K |
0.362 |
|
| 1990 |
Vanderheyden JL, Ketring AR, Libson K, Heeg MJ, Roecker L, Motz P, Whittle R, Elder RC, Deutsch E. Synthesis and characterization of cationic technetium complexes of 1,2-bis(dimethylphosphino)ethane (DMPE). Structure determinations of trans-[TcV(DMPE)2(OH)(O)](F3CSO3)2, trans-[TcIII(DMPE)2Cl2]F3CSO3, and [TcI(DMPE)3]+ using x-ray diffraction, EXAFS, and technetium-99 NMR [Erratum to document cited in CA101(16):142794q] Inorganic Chemistry. 29: 4840-4840. DOI: 10.1021/Ic00348A052 |
0.516 |
|
| 1989 |
Deutsch E, Ketring AR, Libson K, Vanderheyden JL, Hirth WW. The Noah's Ark experiment: species dependent biodistributions of cationic 99mTc complexes. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 16: 191-232. PMID 2497089 DOI: 10.1016/0883-2897(89)90003-2 |
0.463 |
|
| 1986 |
Deutsch E, Libson K, Vanderheyden JL, Ketring AR, Maxon HR. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 13: 465-77. PMID 3793504 DOI: 10.1016/0883-2897(86)90027-9 |
0.509 |
|
| 1984 |
Gerson MC, Deutsch EA, Libson KF, Adolph RJ, Ketring AR, Vanderheyden JL, Williams CC, Saenger EL. Myocardial scintigraphy with 99mTc-tris-DMPE in man. European Journal of Nuclear Medicine. 9: 403-7. PMID 6499874 DOI: 10.1007/Bf00295574 |
0.416 |
|
| 1984 |
Ketring AR, Troutner DE, Hoffman TJ, Stanton DK, Volkert WA, Holmes RA. Biodistribution of lipophilic 99mTc complexes of cyclam derivatives. International Journal of Nuclear Medicine and Biology. 11: 113-9. PMID 6480254 DOI: 10.1016/0047-0740(84)90046-9 |
0.324 |
|
| 1984 |
Weininger J, Ketring AR, Deutsch EA. 186Re-HEDP: a potential therapeutic bone agent. Nuklearmedizin. Nuclear Medicine. 23: 81-2. PMID 6433325 |
0.452 |
|
| 1984 |
Vanderheyden JL, Ketring AR, Libson K, Heeg MJ, Roecker L, Motz P, Whittle R, Elder RC, Deutsch E. Synthesis and characterization of cationic technetium complexes of 1,2-bis(dimethylphosphino)ethane (DMPE). Structure determinations of trans-[TcV(DMPE)2(OH)(O)](F3CSO3)2, trans-[TcIII(DMPE)2Cl2]F3CSO3, and [TcI(DMPE)3]+ using x-ray diffraction, EXAFS, and technetium-99 NMR Inorganic Chemistry. 23: 3184-3191. DOI: 10.1021/Ic00188A031 |
0.553 |
|
| 1983 |
Vanderheyden JL, Libson K, Nosco DL, Ketring AR, Deutsch E. Preparation and characterization of [99mTc(DMPE)2X2]+, X = Cl, Br (DMPE = 1,2-bis(dimethylphosphino)ethane). The International Journal of Applied Radiation and Isotopes. 34: 1611-8. PMID 6668086 DOI: 10.1016/0020-708X(83)90007-8 |
0.471 |
|
| Show low-probability matches. |